PSI

Life Saving Solutions

Pharmacovigilance

We are hiring

PRODUCTS

Wide range of sterile and injectable products in different therapeutic groups

Standard and Pre-Mixed Solutions

Haemodialysis Solutions

Oral Solutions

Pain Management

Anti-Muscarinic Agents

Anti-Infective Products

Ophthalmic Solitions

Respiratory Inhalation Solutions

Iron Supplement

Standard IV Solutions

• Basic (Standard) Large Volume Parenterals
• Basic (Standard) Small Volume Parenterals
• Plasma Volume Substitutes
• Pre-mixed I.V. Solutions
• Irrigation Solutions
• Water for Reconstitution
• Distilled Water

Haemodialysis Solutions (H.D.)

Oral Solutions

Pain Management

• Antipyretic & Analgesic Agents
• Local Anaesthetics

Anti-Muscarinic Agents

Anti-Infective Products

Respiratory Inhalation Solutions

Ophthalmic Solutions

Iron Supplement

ABOUT

Pharmaceutical Solutions Industry (PSI) is a leading injectable manufacturer in Middle East and Africa (MEA).

Our manufacturing facilities are GMP certified and equipped with latest production technologies, we have over 45 years of proven reliable experience worldwide in providing high-quality products and contract manufacturing of sterile and injectable pharmaceutical solutions in plastic and glass bottles, PVC and Non-PVC bags, as well as plastic ampoules. We have a broad range of products from different therapeutic groups and we work persistently to make them accessible to people who need them.

Headquartered in Jeddah, Saudi Arabia, we have a position at the heart of Middle East and Africa allows us to contact and supply all our regional customers quickly and efficiently. We have successfully grown to expand our portfolio, catering to the needs of both domestic and export markets.

In 2016, PSI announced its newest product Ambaprofen®/Ambafen® the first Ibuprofen intravenous (IV) infusion (400mg/100ml) in the world. Successfully registered through health authorities in Germany, Spain, Saudi Arabia, and many other countries in the world, its patent has been granted by the European Patent Office (EPO patent no: 2636406); United States Patent and Trademark Office (uspto Patent No: US 9351926 B2) for its dosage form with the approval of the European Medicines Agency (EMA).

Corporate Social Responsibility

Our social responsibility strategy is inspired by our mission and values to work for a healthier and better world. We are proud of being a responsible company, highly committed to helping patients, support local communities, develop our people and minimize environmental impact.

We work closely with governmental organizations in the countries that we operate in to synergize and maximize our contribution through governmental initiatives.

We do business with integrity and respect the laws of the countries in which we operate. We strictly adhere to good manufacturing and management practices to maintain high quality standards in terms of products and human behaviour.

We aim for excellence. Always challenging our methods and revising our reporting and accountability systems guaranteeing sustainability of long term values to our stakeholders.

FACILITIES

Pharmaceutical Solutions Industry (PSI) is a leading injectable manufacturer in Middle East and Africa (MEA).

Production

Our state of the art production facilities coupled with organizational flexibility enables us to efficiently adapt to any customer requirement.

Quality

At PSI, the quality management system is designed, operated, and maintained as per Saudi FDA GMP guidelines and complies with various international standards like GCC-DR, ISO 9001, and CE.

Supply Chain

Our state of the art warehouse facilities use the latest ERP system (SAP) combined with our integrated computerized supply chain to offer a superior service to our customer.

Regulatory

Keeping track of the ever-changing policies and requirements to protect public health by controlling the safety and efficacy of products.

We have global regulatory experience ..

Over 2 Billion Patients Served

1 B

Patients

1.9 K+

Hospitals

Countries

Innovation

Product development, stability studies, process control, and continuous improvement form the backbone of PSI’s high quality products and the engine of company growth.

We look beyond the generic industry for opportunities of developing new dosage forms for exist molecules to fill such gaps in the pharmaceutical industry. Through such strategy, PSI has received a worldwide patency for Ambafen / Ambaprofen as the first Ibuprofen IV Infusion in the world.

People

Our beliefs on the pharmaceutical manufacturing is that the highest quality level can only be achieved through talented people, excellent processes and state of art technology. With a workforce of 800+ , PSI paves its way from planning to production with high standards of safety, quality, and efficacy of its products and innovations. Our culture endorses personal and professional growth. Our staff are our assets and are encouraged to learn and develop while they are working and making difference in the lives of millions of people through quality health services. We manufacture and deliver Life Saving Solutions through our high calibre and innovative teams.

Join us